retatrutide clinical trial phase 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide approval: FDA status, clinical

In contrast, treating obesity with GLP-1RA decreases cardiovascular risk and the possible mechanisms of cardioprotection achieved by this class of drugs are discussed

Always great reporting and enjoyed contributing to this article from The New York Times and Dani Blum on the evolution of the GLP-1 market, specifically the growth of grey and illicit markets online

Semaglutide medications may be making you tired, and there's a reason why

Herbal medicines for diabetic therapy are widely used with acceptable efficacy but unsatisfied in advances

muciniphila, a novel probiotic known for its exceptional ability to strengthen intestinal lining and gut barrier function.* Our formula combines green tea leaf and EGCG, a unique blend

Whether you are curious for yourself or a loved one, gain practical, evidence-based guidance on this emerging class of medications.